Investigation of cancer drug resistance mechanisms by phosphoproteomics
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference119 articles.
1. The quest to overcome resistance to egfr-targeted therapies in cancer;Chong;Nat. Med.,2013
2. Adaptive protein and phosphoprotein networks which promote therapeutic sensitivity or acquired resistance;Haley,2014
3. Quantitative analysis of egfrviii cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma;Huang;Proc. Natl. Acad. Sci.,2007
4. Is phosphoproteomics ready for clinical research?;Iliuk;Clin. Chim. Acta,2013
5. Quantitative phosphoproteomics-based molecular network description for high-resolution kinase-substrate interactome analysis;Narushima;Bioinformatics,2016
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer;Pharmaceutics;2024-09-07
2. EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3;Cellular and Molecular Life Sciences;2024-05-25
3. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance;Biochemical Pharmacology;2024-03
4. Phosphoprotein dynamics of interacting T cells and tumor cells by HySic;Cell Reports;2024-01
5. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance;Drug Resistance Updates;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3